Sublingual immunotherapy for the treatment of allergy symptoms caused by a wide variety of environmental inhalants has been effectively used in Europe. It should be employed to further treatment of allergies in the United States, where allergic symptoms are largely undertreated, according to an invited... 

Phadia, the world leader in in vitro allergy diagnostics, is pleased to announce the recent United States Food and Drug Administration clearance of ImmunoCAP® Rapid, the first point-of-care test to assist in the diagnosis of allergy in the physician’s office. “This is another significant... 

Mom, actress and allergy sufferer Alison Sweeney knows first hand how symptoms like congestion can make juggling a busy career and family life even more challenging. That’s why she’s teamed up with the American Pharmacists Association (APhA) and McNeil Consumer Healthcare Division of McNEIL-PPC,... 

A study published in Journal of Insurance Medicine by members of the Celiac Disease Center at Columbia University Medical Center has demonstrated an economic benefit to the diagnosis of celiac disease in a national managed-care population in the United States. Peter HR Green, M.D., Professor of Clinical... 

Jennifer Derebery, M.D., physician at the House Clinic and leading expert on the treatment of allergies, believes there a several options available to people with significant symptoms before starting allergy shots. “One option that is not well known at this time is prescription intranasal sprays,... 

A new study finds that a botanical drug could provide the key to new treatments for peanut allergies. The findings are published online in The Journal of Allergy and Clinical Immunology. Lead author Xiu-Min Li, MD, Associate Professor of Pediatrics and Director of Center for Chinese Herbal Therapy for... 

Schering-Plough Corporation (NYSE: SGP) announces the introduction of new CLARITIN(R) Liqui-Gels(R), the first and only non-drowsy allergy medicine in an easy-to-swallow liquid-filled capsule. Now available over-the-counter, CLARITIN(R) Liqui-Gels(R) provide powerful liquid relief for the worst allergy... 

Schering-Plough Corporation (NYSE: SGP) announces the introduction of new CLARITIN(R) Liqui-Gels(R), the first and only non-drowsy allergy medicine in an easy-to-swallow liquid-filled capsule. Now available over-the-counter, CLARITIN(R) Liqui-Gels(R) provide powerful liquid relief for the worst allergy... 

Circassia Ltd, a specialty biopharmaceutical company focused on allergy and critical care, announced that following successful clinical results achieved in 2008 with its ToleroMune(R) anti-allergy technology, the company has now completed patient recruitment for a further phase II clinical trial in cat... 

Researchers in Germany are reporting an advance toward development of technology that could make life easier for millions of people allergic to plant pollen. It could underpin the first automated, real-time systems for identifying specific kinds of allergy-inducing plant pollen circulating in the air....